Abeona Therapeutics Inc. 0H7R.L
0H7R.L
Abeona Therapeutics Inc. 0R1D.L
Sangamo Therapeutics, Inc. 0H8T.L
Aclaris Therapeutics, Inc. 0J4V.L
Heron Therapeutics, Inc. 0IFK.L
Editas Medicine, Inc. 0KCC.L
Insight Molecular Diagnostics Inc. 0HIY.L
Atara Biotherapeutics, Inc. 0JW9.L
Lite Strategy, Inc. 0IL8.L
FibroGen, Inc. 0HX7.L
Adicet Bio, Inc.
Abeona Therapeutics Inc. 0R1D.L
Sangamo Therapeutics, Inc. 0H8T.L
Aclaris Therapeutics, Inc. 0J4V.L
Heron Therapeutics, Inc. 0IFK.L
Editas Medicine, Inc. 0KCC.L
Insight Molecular Diagnostics Inc. 0HIY.L
Atara Biotherapeutics, Inc. 0JW9.L
Lite Strategy, Inc. 0IL8.L
FibroGen, Inc. 0HX7.L
Adicet Bio, Inc.
Performance
| Periode | 0H7R.L | 0R1D.L | 0H8T.L | 0J4V.L | 0IFK.L | 0KCC.L | 0HIY.L | 0JW9.L | 0IL8.L | 0HX7.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 19.93 % | -3.75 % | 62.33 % | -29.23 % | 204.72 % | 35.23 % | 176.75 % | 34.76 % | 45.47 % | 75.62 % |
| YTD | -7.61 % | -35.46 % | -25.87 % | -20.55 % | 182.48 % | 64.50 % | 3.73 % | -10.00 % | -19.96 % | -8.28 % |
| 1Y | -15.50 % | -25.96 % | 55.62 % | -26.84 % | 22.47 % | 25.41 % | 85.64 % | -5.62 % | 21.90 % | -36.66 % |
| 3Y | 10.06 % | -85.43 % | -88.54 % | -63.91 % | -66.70 % | -75.00 % | -83.64 % | -64.71 % | -97.20 % | -94.38 % |
| 5Y | -86.63 % | -88.65 % | -73.37 % | -93.85 % | -80.52 % | 37.68 % | -42.35 % | -95.79 % | -97.14 % | -93.48 % |
| 10Y | -98.61 % | -88.65 % | -92.32 % | -94.67 % | -80.52 % | 1 776.54 % | -33.63 % | -94.30 % | -97.14 % | -93.48 % |
| From the beginning | -98.61 % | -88.65 % | -92.32 % | -94.67 % | -80.52 % | 1 776.54 % | -33.63 % | -94.30 % | -97.14 % | -93.48 % |